(MKOR) Matthews International - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US5771257848 • Miscellaneous Region
MKOR: South Korean, Stocks, Equities
The Matthews International Funds ETF (Ticker: MKOR) is a U.S.-based exchange-traded fund designed to provide exposure to the South Korean equity market. Under normal market conditions, the fund allocates at least 80% of its net assets, including borrowings for investment purposes, to common and preferred stocks of companies domiciled in South Korea. This focus allows investors to gain targeted exposure to one of Asias leading economies, known for its advanced technology sector and manufacturing capabilities. The fund is categorized under Miscellaneous Region ETFs, reflecting its specific geographic focus.
From a technical standpoint, MKOR is currently trading below its key moving averages, with the last price of $21.64 falling under the 20-day SMA of $22.33, 50-day SMA of $21.98, and 200-day SMA of $23.40. This indicates bearish momentum in the short to medium term. The Average True Range (ATR) of 0.27 suggests relatively low volatility, with the stock exhibiting limited price fluctuations. Average daily volume of 2,822 shares highlights modest trading activity, which may impact liquidity for larger positions.
Fundamentally, the ETF manages assets under management (AUM) of $45.89 million, placing it in the smaller category of ETFs. This smaller size may result in higher expense ratios compared to larger funds and could limit its diversification benefits. Investors should consider these factors when evaluating the funds potential role in their portfolios.
3-Month Forecast
Based on the current technical and fundamental data, MKOR is expected to face headwinds in the near term. The funds price is below its key moving averages, signaling bearish momentum. However, the low ATR suggests that price movements will likely remain contained, with potential sideways trading. The funds exposure to South Koreas economy, particularly its technology and manufacturing sectors, could provide support if global sentiment improves. Still, the broader market trends and geopolitical factors will play a significant role in shaping the funds performance over the next three months.
Additional Sources for MKOR ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MKOR ETF Overview
Market Cap in USD | 47m |
Category | Miscellaneous Region |
TER | 0.79% |
IPO / Inception | 2010-10-29 |
MKOR ETF Ratings
Growth Rating | -40.1 |
Fundamental | - |
Dividend Rating | 18.9 |
Rel. Strength | -16.3 |
Analysts | - |
Fair Price Momentum | 20.27 USD |
Fair Price DCF | - |
MKOR Dividends
Dividend Yield 12m | 4.78% |
Yield on Cost 5y | 4.35% |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
MKOR Growth Ratios
Growth Correlation 3m | -12.4% |
Growth Correlation 12m | -80.7% |
Growth Correlation 5y | -36.1% |
CAGR 5y | -5.24% |
CAGR/Max DD 5y | -0.24 |
Sharpe Ratio 12m | 0.42 |
Alpha | -15.77 |
Beta | 0.627 |
Volatility | 17.33% |
Current Volume | 0.8k |
Average Volume 20d | 1.6k |
As of May 10, 2025, the stock is trading at USD 22.85 with a total of 797 shares traded.
Over the past week, the price has changed by +0.30%, over one month by +7.48%, over three months by +2.35% and over the past year by -8.02%.
Probably not. Based on ValueRay Analyses, Matthews International (NYSE ARCA:MKOR) is currently (May 2025) not a good stock to buy. It has a ValueRay Growth Rating of -40.08 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MKOR as of May 2025 is 20.27. This means that MKOR is currently overvalued and has a potential downside of -11.29%.
Matthews International has no consensus analysts rating.
According to ValueRays Forecast Model, MKOR Matthews International will be worth about 22.4 in May 2026. The stock is currently trading at 22.85. This means that the stock has a potential downside of -1.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 22.4 | -1.8% |